A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4422 (2006.01) A61K 31/198 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2761298
The present invention provides, among other things, therapeutic compositions and methods that can effectively treat, slow or prevent mild cognitive impairment (MCI) or Alzheimer's disease (AD), in particular, based on therapeutically effective amount of nifedipine, oxidized or nitroso nifedipine derivatives, thyroxine (T4), triiodothyronine (T3) and combinations thereof.
L'invention concerne, entre autres, des compositions thérapeutiques et des méthodes destinées à traiter, ralentir ou prévenir efficacement le trouble cognitif léger ou la maladie d'Alzheimer, notamment par l'administration d'une quantité thérapeutiquement efficace de nifédipine, de dérivés de nitroso-nifédipine ou de nifédipine oxydée, de thyroxine (T4), de triiodothyronine (T3) et de combinaisons de ceux-ci.
Lovell Mark
Lynn Bert
Fasken Martineau Dumoulin Llp
The University Of Kentucky Research Foundation
LandOfFree
Treatment of mci and alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of mci and alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of mci and alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1540642